XML 57 R37.htm IDEA: XBRL DOCUMENT
v3.25.4

Intangible Assets and Goodwill (Tables) | 12 Months Ended
--- | ---
Dec. 28, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets and Goodwill | As of December 28, 2025 and December 29, 2024, the gross and net amounts of intangible assets were:
|  |  |  |  |  | December 28, 2025 |  | December 29, 2024
(Dollars in Millions) |  |  |  |  |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Definite-lived intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patents and trademarks |  |  |  |  |  | $ | 4,406 |  |  | $ | (2,054) |  |  | $ | 2,352 |  |  | $ | 4,110 |  |  | $ | (1,780) |  |  | $ | 2,330 |
Customer relationships |  |  |  |  |  | 2,049 |  |  | (1,178) |  |  | 871 |  |  | 1,933 |  | (1,074) |  | 859 |
Other intangibles(1) |  |  |  |  |  | 1,329 |  |  | (760) |  |  | 569 |  |  | 1,276 |  | (694) |  | 582 |
Total definite-lived intangible assets |  |  |  |  |  | $ | 7,784 |  |  | $ | (3,992) |  |  | $ | 3,792 |  |  | $ | 7,319 |  |  | $ | (3,548) |  |  | $ | 3,771 |
Indefinite-lived intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trademarks |  |  |  |  |  | $ | 4,840 |  |  | $ | — |  |  | $ | 4,840 |  |  | $ | 4,648 |  |  | $ | — |  |  | $ | 4,648 |
Other |  |  |  |  |  | 62 |  |  | — |  |  | 62 |  |  | 55 |  | — |  |  | 55 |
Total intangible assets, net |  |  |  |  |  | $ | 12,686 |  |  | $ | (3,992) |  |  | $ | 8,694 |  |  | $ | 12,022 |  |  | $ | (3,548) |  |  | $ | 8,474 |
(1) The majority of the other intangible assets balance relates to the acquisition of Pfizer Consumer Health in 2006.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | The schedule of amortization expense for the five succeeding fiscal years is as follows:
|  |  |  |  |  | (Dollars in Millions) |  |  |  |  |  |  |  |
|  |  |  |  |  | 2026 |  | 2027 |  | 2028 |  | 2029 |  | 2030
|  |  |  |  |  | $ | 260 |  |  | $ | 252 |  |  | $ | 252 |  |  | $ | 248 |  |  | $ | 245 |
Goodwill | The following table summarizes the changes in the carrying amount of goodwill by reportable business segment during the fiscal twelve months ended December 28, 2025 and December 29, 2024:
(Dollars in Millions) |  |  |  |  |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total Goodwill(1)
December 31, 2023 |  |  |  |  |  | $ | 5,308 |  |  | $ | 2,315 |  |  | $ | 1,648 |  |  | $ | 9,271 |
Currency translation |  |  |  |  |  | (254) |  |  | (130) |  |  | (44) |  |  | (428) |
December 29, 2024 |  |  |  |  |  | 5,054 |  |  | 2,185 |  |  | 1,604 |  |  | 8,843 |
Currency translation |  |  |  |  |  | 508 |  |  | 78 |  |  | 80 |  |  | 666 |
December 28, 2025 |  |  |  |  |  | $ | 5,562 |  |  | $ | 2,263 |  |  | $ | 1,684 |  |  | $ | 9,509 |
(1) The majority of the Goodwill balance relates to the acquisition of Pfizer Consumer Health in 2006.

X
- Definition Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block] + References No definition available. + Details
Name: | kvue_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock
Namespace Prefix: | kvue_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 55 -Paragraph 40 -SubTopic 30 -Topic 350 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration